https://pharmadog.xyz/news/536895 pharmadog en 2026-10-13T21:00:00.000Z Connectivity in fluid management systems key to reducing process variability https://pharmadog.xyz/news/536727 pharmadog en 2026-10-13T20:35:00.000Z Paragon spinout Velaris Therapeutics goes public via reverse merger with Alaunos, raising $350 million https://pharmadog.xyz/news/536707 pharmadog en 2026-10-13T20:25:40.000Z BlackRock to acquire majority stake in Humana’s CenterWell clinics for $2.8 billion https://pharmadog.xyz/news/536495 pharmadog en 2026-10-13T19:04:39.000Z FTC and seven states seek contempt order against Martin Shkreli for breaching lifetime pharma ban https://pharmadog.xyz/news/536327 pharmadog en 2026-10-13T18:51:04.000Z Novartis secures supplemental FDA approval to market repurposed antibiotic Lamprene in the US https://pharmadog.xyz/news/536371 pharmadog en 2026-10-13T18:11:36.000Z Veteran infectious disease journalist Helen Branswell dies at 69 https://pharmadog.xyz/news/536095 pharmadog en 2026-10-13T18:00:13.000Z Study finds nearly 40% of FDA advisory panels include reps linked to pharma-funded advocacy groups https://pharmadog.xyz/news/536051 pharmadog en 2026-10-13T17:42:27.000Z Verdiva Bio halts mid-stage obesity trial of its GLP-1 pill, citing market evolution https://pharmadog.xyz/news/535883 pharmadog en 2026-10-13T16:54:10.000Z Soufflé Therapeutics raises $135 million to develop three RNA medicines https://pharmadog.xyz/news/535947 pharmadog en 2026-10-13T16:24:00.000Z BioNTech's mRNA cancer therapy fails to improve progression-free survival in head-neck cancer trial https://pharmadog.xyz/news/535927 pharmadog en 2026-10-13T16:07:06.000Z North Carolina public worker health plan faces court challenge over provider restrictions https://pharmadog.xyz/news/535779 pharmadog en 2026-10-13T15:49:00.000Z Roche signs $1 billion deal with China’s Rona Therapeutics for RNAi obesity drug https://pharmadog.xyz/news/535759 pharmadog en 2026-10-13T15:43:56.000Z Doctors donate heavily to fellow physicians running for office amid Medicare overhaul debate https://pharmadog.xyz/news/535715 pharmadog en 2026-10-13T15:37:36.000Z Beam Therapeutics reports early Phase 1/2 data for base editing therapy in GSD Ia, partners with Pfizer and Enodia https://pharmadog.xyz/news/535739 pharmadog en 2026-10-13T15:20:01.000Z J&J’s innovative medicines carried Q3 as medtech disappoints, but newer medicines absent https://pharmadog.xyz/news/535740 pharmadog en 2026-10-13T15:00:29.000Z BioNTech's head and neck cancer mRNA vaccine fails to extend progression-free survival in Phase 3 trial https://pharmadog.xyz/news/535547 pharmadog en 2026-10-13T15:00:01.000Z Rudy Tanzi says he may be nearing a cheap, safe Alzheimer’s prevention pill https://pharmadog.xyz/news/535548 pharmadog en 2026-10-13T14:59:28.000Z BioNTech's head and neck cancer vaccine fails to meet first primary endpoint in pivotal trial https://pharmadog.xyz/news/535549 pharmadog en 2026-10-13T14:56:16.000Z Health tech firms expand AI scribing tools toward prescribing and billing functions https://pharmadog.xyz/news/535591 pharmadog en 2026-10-13T14:31:08.000Z FTC and seven states seek contempt order against Martin Shkreli for breaching pharma work ban https://pharmadog.xyz/news/535571 pharmadog en 2026-10-13T14:27:21.000Z Roche expands obesity R&D footprint with Rona deal worth $1B+ https://pharmadog.xyz/news/535423 pharmadog en 2026-10-13T13:29:22.000Z Patient advocates and experts raise alarm over safety of Neurocrine Biosciences rare disease drug https://pharmadog.xyz/news/535424 pharmadog en 2026-10-13T13:13:25.000Z Lancet study assesses performance of Google’s diagnostic chatbot AMIE https://pharmadog.xyz/news/535379 pharmadog en 2026-10-13T13:00:59.000Z Readily secures $11 million to expand AI compliance platform for insurers https://pharmadog.xyz/news/535235 pharmadog en 2026-10-13T12:55:29.000Z Syndax halts Niktimvo trial for idiopathic pulmonary fibrosis after mid-stage failure https://pharmadog.xyz/news/535236 pharmadog en 2026-10-13T12:09:59.000Z Pfizer strikes over $500M partnership with Enodia to develop Sec61-targeting small-molecule drugs https://pharmadog.xyz/news/535087 pharmadog en 2026-10-13T11:46:54.000Z Trump administration proposes $70,000 fee to curb foreign student work authorizations https://pharmadog.xyz/news/535043 pharmadog en 2026-10-13T11:00:48.000Z Paragon Labs launches ninth biotech, Velaris Therapeutics, via reverse merger to bring cardiopulmonary drugs to Alaunos https://pharmadog.xyz/news/535044 pharmadog en 2026-10-13T11:00:35.000Z Former Apogee Therapeutics leaders join Paragon Labs to expand R&D and company creation platform https://pharmadog.xyz/news/534791 pharmadog en 2026-10-13T10:34:16.000Z Analysts focus on RevMed pancreatic cancer launch and Merck data push ahead of Q3 earnings https://pharmadog.xyz/news/534767 pharmadog en 2026-10-13T10:25:02.000Z Syndax halts development of Niktimvo after Phase 2 failure in IPF trial https://pharmadog.xyz/news/534768 pharmadog en 2026-10-13T10:19:03.000Z Roche signs $1.2 bn obesity partnership with China's Rona Therapeutics, paying up to $100 m upfront https://pharmadog.xyz/news/535354 pharmadog en 2026-10-13T08:49:00.000Z BioNTech’s mRNA cancer vaccine misses key endpoint in head-and-neck trial, study to continue https://pharmadog.xyz/news/535355 pharmadog en 2026-10-13T08:46:00.000Z Paragon Labs hires former Apogee leadership after AbbVie acquisition and spins out hypertension unit https://pharmadog.xyz/news/534475 pharmadog en 2026-10-13T08:30:00.000Z Botched lethal injection of Christa Pike raises questions about execution protocols https://pharmadog.xyz/news/534476 pharmadog en 2026-10-13T08:30:00.000Z Safety concerns rise as Neurocrine's Prader-Willi drug linked to deaths and hospitalizations https://pharmadog.xyz/news/534477 pharmadog en 2026-10-13T08:30:00.000Z Physicians Face Learned Helplessness From Training Culture, Says STAT+ Columnist https://pharmadog.xyz/news/535018 pharmadog en 2026-10-13T07:16:00.000Z Roche licenses Rona's ALK7 obesity candidate in $1.2 billion deal https://pharmadog.xyz/news/536154 pharmadog en 2026-10-13T04:00:00.000Z Medline pulls convenience kits containing recalled BD ChloraPrep applicators due to contamination risk https://pharmadog.xyz/news/534406 pharmadog en 2026-10-13T03:24:00.000Z Nurix halts development of BTK degrader zelebrudomide after phase 1 review https://pharmadog.xyz/news/535858 pharmadog en 2026-10-13T01:42:00.000Z Insulet launches full U.S. release of Omnipod Discover data platform for Omnipod 5 users https://pharmadog.xyz/news/536569 pharmadog en 2026-10-13T00:00:00.000Z Roche signs $1.2B partnership with China’s Rona for obesity drug as Stryker pours $400M into CMR Surgical https://pharmadog.xyz/news/532431 pharmadog en 2026-10-12T21:26:00.000Z First Tracks reports positive early-stage results for celiac drug ANB033 https://pharmadog.xyz/news/531943 pharmadog en 2026-10-12T18:18:36.000Z Merck's diabetic eye-disease drug hits primary goal but faces commercial doubts https://pharmadog.xyz/news/531775 pharmadog en 2026-10-12T17:08:13.000Z Asahi Kasei Therapeutics receives FDA approval for HSV drug acquired in $1 billion deal https://pharmadog.xyz/news/531671 pharmadog en 2026-10-12T15:58:00.000Z Aspen Neuroscience files for Nasdaq IPO to fund Parkinson’s cell therapy program https://pharmadog.xyz/news/531415 pharmadog en 2026-10-12T15:35:00.000Z Bristol Myers' lung drug admilparant meets Phase 3 goal at low dose, high dose falls short https://pharmadog.xyz/news/531351 pharmadog en 2026-10-12T15:12:41.000Z Mirum's Livmarli cuts itching in ultra-rare liver disease trial, showing significant benefit https://pharmadog.xyz/news/531375 pharmadog en 2026-10-12T15:04:54.000Z BMS lung drug meets low-dose endpoint in Phase 3 but high dose fails to improve lung function https://pharmadog.xyz/news/531352 pharmadog en 2026-10-12T15:04:37.000Z Bristol Myers reports two Phase 3 successes for fibrosis and RayzeBio drug https://pharmadog.xyz/news/531183 pharmadog en 2026-10-12T14:52:00.000Z Bausch + Lomb CEO Brent Saunders abruptly departs after failed multibillion-dollar sale https://pharmadog.xyz/news/531184 pharmadog en 2026-10-12T14:48:57.000Z GSK allocates over $800 million to expand R&D and manufacturing hub in Pennsylvania https://pharmadog.xyz/news/531039 pharmadog en 2026-10-12T13:34:43.000Z RevMed's pancreatic cancer drug Rasonque shows mixed results across KRAS subtypes, analysts stay optimistic https://pharmadog.xyz/news/531040 pharmadog en 2026-10-12T13:24:52.000Z BMS reports Phase 3 success for RYZ101 in GEP-NET trial https://pharmadog.xyz/news/531079 pharmadog en 2026-10-12T13:16:00.000Z Pharma faces $500B risk as patents expire, with Merck most exposed by 2028 https://pharmadog.xyz/news/531674 pharmadog en 2026-10-12T12:09:00.000Z Bausch + Lomb appoints board chair Thomas Appio as interim CEO after Brent Saunders departs https://pharmadog.xyz/news/530703 pharmadog en 2026-10-12T11:21:45.000Z GSK to invest $800 million in new biologics manufacturing hub in Pennsylvania https://pharmadog.xyz/news/530679 pharmadog en 2026-10-12T11:00:35.000Z Undecimal Bio raises $18 million to expand siRNA platform beyond liver diseases https://pharmadog.xyz/news/530990 pharmadog en 2026-10-12T09:42:00.000Z Roche reports updated eye drug data and FDA filing acceptance, targets July 2027 decision https://pharmadog.xyz/news/530991 pharmadog en 2026-10-12T09:25:00.000Z Tortugas Neuroscience's obuprazine shows significant improvement in phase 2b schizophrenia trial in China https://pharmadog.xyz/news/530822 pharmadog en 2026-10-12T08:06:00.000Z BMS reports phase 3 successes in IPF drug and neuroendocrine tumor radiotherapy https://pharmadog.xyz/news/530031 pharmadog en 2026-10-12T07:00:00.000Z Strategic CDMO partnerships shift from transactional to collaborative, emphasizing risk sharing and regulatory expertise https://pharmadog.xyz/news/529587 pharmadog en 2026-10-12T05:01:00.000Z Integrating Multiple Stability Measurements Improves Early Biologics Testing https://pharmadog.xyz/news/529982 pharmadog en 2026-10-12T02:55:00.000Z Merck’s deeper dive into efficacy, safety of $1.3B eye disease drug raises fears of ‘limited’ potential https://pharmadog.xyz/news/532611 pharmadog en 2026-10-12T00:00:00.000Z Japan's PMDA Issues Guidance to Safeguard Participants in Generic Bioequivalence Trials https://pharmadog.xyz/news/532609 pharmadog en 2026-10-12T00:00:00.000Z Europe’s share of clinical trials falls 13.5% as Asia’s research footprint expands https://pharmadog.xyz/news/532610 pharmadog en 2026-10-12T00:00:00.000Z FDA finalizes guidance aligning biosimilar post-approval manufacturing changes with global standards https://pharmadog.xyz/news/532612 pharmadog en 2026-10-12T00:00:00.000Z FDA approves new treatments for persistent herpes and schizophrenia; Steris to acquire Xodus Medical for $2.1 billion